G Medical Innovations Holdings Ltd.
5 Oppenheimer St.
Rehovot, Israel 7670105
May 26, 2022
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
RE: | G Medical Innovations Holdings Ltd. (CIK: 0001760764) | |
Registration Statement No. 333-265089 on Form F-1 (the “Registration Statement”) | ||
Request for Acceleration of Effective Date |
Ladies and Gentlemen:
G Medical Innovations Holdings Ltd. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective on May 31, 2022 at 6:00 a.m., Eastern Time, or as soon thereafter as is practicable.
The Registrant understands that the Securities and Exchange Commission will consider this request for acceleration of the effective date of the Registration Statement as a confirmation of the fact that the Registrant is aware of its responsibilities under the Securities Act as they relate to the proposed public offering of the securities specified in the Registration Statement.
The Registrant respectfully requests that it be notified of such effectiveness by a telephone call to Eric Victorson of Sullivan & Worcester LLP at (212) 660 3092 and that such effectiveness also be confirmed in writing.
Very truly yours, | |||
G Medical Innovations Holdings Ltd. | |||
By: | /s/ Yacov Geva | ||
Name: | Yacov Geva | ||
Title: | Chief Executive Officer |